Danelfin | AI Stock Picker to Find the Best Stocks
Start TrialLog In
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • All
Advanced Chart
Custom range→
Custom range→

INMB AI-Powered Stock Analysis

AI Score Explanation

Danelfin Loading

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Alpha Factors

These AI Factors group the most impactful alpha signals used by Danelfin's AI to calculate the stock’s probability advantage. Positive factors (green) increase the probability of beating the market, while negative factors (red) reduce it.

  • Size & Liquidity+0.23%
    Company size and trading liquidity
  • Earnings Quality+0.20%
    Stability and reliability of reported earnings
  • Valuation+0.16%
    How the stock is priced relative to its fundamentals
  • Volatility+0.07%
    How much the stock price tends to fluctuate
  • Momentum-3.84%
    Direction and strength of recent price movements
  • Sentiment-0.42%
    How analysts and the market view the stock

INMB probability advantage of beating the market (3M):

-3.61%

Alpha Signals: What Drives the AI Score

Alpha Signals show the individual signals used by Danelfin's AI to calculate a stock's probability of beating the market over the next 3 months. Each signal highlights its positive or negative impact on the probability advantage and helps explain what is driving the AI Score.

AI Score
Sell

INmune Bio (INMB) has an AI Score of 3/10 (Sell) because, according to an overall analysis, it has a probability advantage of -3.61% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of INMB (47.21%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

  • Average probability of any US-listed stock of beating the market (3M)50.82%
  • INMB probability advantage of beating the market (3M)-3.61%
  • INMB probability of beating the market (3M)47.21%

INMB probability advantage of beating the market (3M): -3.61%

The AI-powered overall analysis of INmune Bio (INMB) is based on the 25 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of INMB:

Type
Alpha Signal
Current Value
Value Decile Position
Probability Advantage Impact (3M)
Technical
Chart Pattern (504d)
figure_94
N/A
-1.29%
Technical
Chart Pattern (120d)
figure_139
N/A
-1.14%
Technical
Technicals Impact (Long Tail)
-
N/A
+1.07%
Fundamental
Fundamentals Impact (Long Tail)
-
N/A
+1.00%
Technical
Chart Pattern (60d)
figure_168
N/A
-0.91%
Technical
Chart Pattern (180d)
figure_15
N/A
-0.80%
Sentiment
Fear & Greed Index (CNN)
31
N/A
-0.78%
Technical
Distance from KAMA (20d)
0.21%
+-
-0.56%
Technical
Maximum Volatility
13.11%
+-
-0.54%
Technical
ATR (90d Volatility)
0.15
N/A
+0.45%
Technical
Upgrade to unlock
+0.41%
Fundamental
Upgrade to unlock
-0.37%
Technical
Upgrade to unlock
-0.31%
Sentiment
Upgrade to unlock
+0.30%
Fundamental
Upgrade to unlock
-0.30%
Rest of Alpha Signals: +0.15%
  • INMB probability advantage of beating the market (3M)Total:-3.61%
  • INMB AI Score
Significant changes Vs previous day

INMB Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

  • Entry:$1.72
  • Horizon: 3 months
  • Stop Loss:$XXXXXPro (XXXXXPro)
  • Take Profit:$XXXXXPro (XXXXX)

INMB Average Past Performance & Loss Rate

Three months after its 668 Sell signals since July 2026, INMB had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

668 Past INMB Sell Signals
1 Month Later
3 Months Later
6 Months Later
1 Year Later
Average Performance
+2.20%
Average Alpha
-9.17%
Loss Rate (% Negative Perf.)
61.34%
% Negative Alpha
66.23%

INMB Frequently Asked Questions

INmune Bio Inc Company Profile

Pros

Cons

Get Free INMB UpdatesAnd create your first portfolio
  • INMB / US45782T1051US Flag
  • Market Cap$45.19M
  • Short Float-
  • Volume964.46K
  • Dividend %-
Performance
  • Perf Week+15.43%
  • Perf Quarter+39.83%
  • Perf Year-17.70%
  • Perf YTD+10.25%
Technical Indicators
  • 52W High7.37 -76.66%
  • 52W Low1.12 53.57%
  • Avg Volume-
  • Beta-
  • ATR0.13
  • Volatility-

INMB Company Profile Summary

INMB Related Investment Themes

INMB Related Stocks

Company
AI Score
Compare

INMB Top 10 Industry Stocks

Biotechnology

Company
AI Score
Compare
View all

INMB Top 10 Sector Stocks

Health Care

Company
AI Score
Compare
View all